Hap Trading, LLC Corcept Therapeutics Inc Put Options Transaction History

Hap Trading, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2024 May 13, 2024	BUY	$21.1 - $27.46 $1.06 Million - $1.37 Million	50,000 New	50,000 $32.5 Million
Q1 2021 May 14, 2021	SELL	$23.49 - $30.56 $7.06 Million - $9.18 Million	-300,500 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$16.78 - $27.3 $21,814 - $35,490	-1,300 Reduced 0.43%	300,500 $0
Q3 2020 Nov 13, 2020	BUY	$12.46 - $19.98 $17,444 - $27,972	1,400 Added 0.47%	301,800 $145,000
Q2 2020 Aug 10, 2020	BUY	$11.0 - $18.26 $3.3 Million - $5.49 Million	300,400 New	300,400 $180,000
Q1 2019 May 10, 2019	SELL	$10.03 - $15.71 $374,119 - $585,983	-37,300 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$11.29 - $17.19 $421,116 - $641,187	37,300 New	37,300 $116,000

350

86.1M

1.12M

667K

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.92B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.